Showing results (21-30 of 56) with videos related to
Sort By:
Pageof 6
Drug Metabolism and Pharmacokinetics|July 9, 2010
Enhanced susceptibility of HLA-mediated ticlopidine-induced idiosyncratic hepatotoxicity by CYP2B6 polymorphism in JapaneseNoritaka Ariyoshi, Yukako Iga, Koji Hirata, et al.British Journal of Clinical Pharmacology|May 9, 2025
Comprehensive analysis of adverse event profile changes with pertuzumab addition to trastuzumab-based breast cancer therapy: Disproportionality analysis using VigiBaseTatsuaki Takeda, Jun Matsumoto, Tomonori Sakai, et al.Journal of Cardiology|August 28, 2016
Impact of chronic kidney disease on platelet inhibition of clopidogrel and prasugrel in Japanese patientsTakeshi Nishi, Noritaka Ariyoshi, Takashi Nakayama, et al.The Journal of Dermatology|August 9, 2007
Relationship between Kaposi's varicelliform eruption in Japanese patients with atopic dermatitis treated with tacrolimus ointment and genetic polymorphisms in the IL-18 gene promoter regionKouji Osawa, Takafumi Etoh, Noritaka Ariyoshi, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 22, 2011
Degradation of filamin induces contraction of vascular smooth muscle cells in type-I collagen matrix honeycombsMasashi Uchida, Itsuko Ishii, Kaori Hirata, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 9, 2011
Q172H replacement overcomes effects on the metabolism of cyclophosphamide and efavirenz caused by CYP2B6 variant with Arg262Noritaka Ariyoshi, Miyuki Ohara, Mayumi Kaneko, et al.Journal of Atherosclerosis and Thrombosis|June 15, 2010
Kefiran reduces atherosclerosis in rabbits fed a high cholesterol dietMasashi Uchida, Itsuko Ishii, Chika Inoue, et al.Biochemistry|December 24, 2003
Direct interaction between substrates and endogenous steroids in the active site may change the activity of cytochrome P450 3A4Nao Torimoto, Itsuko Ishii, Masayuki Hata, et al.International Journal of Clinical Pharmacy|January 19, 2024
A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databasesTatsuaki Takeda, Shiho Sugimoto, Jun Matsumoto, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 20, 2018
Minor contribution of CYP3A5 to the metabolism of hepatitis C protease inhibitor paritaprevir in vitroSu Nwe San, Jun Matsumoto, Yumi Saito, et al.Pageof 6